(Q85640217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Jingli Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Shuo Qiu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yujian Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Maria Merino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Patricia Fetsch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Itzhak Avital

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Armando Filie

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ira Pastan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Raffit Hassan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

5151-5158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin

20 February 2020

cites work

1 reference

12 December 2020

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

1 reference

12 December 2020

Value of mesothelin immunostaining in the diagnosis of mesothelioma.

1 reference

12 December 2020

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

12 December 2020

Application of Mesothelin Immunostaining in Tumor Diagnosis

1 reference

12 December 2020

Mesothelin-family proteins and diagnosis of mesothelioma

1 reference

12 December 2020

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

1 reference

12 December 2020

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

1 reference

12 December 2020

Mesothelin: a new target for immunotherapy

1 reference

12 December 2020

Simultaneous detection of HER2/neu gene amplification and protein overexpression in paraffin-embedded breast cancer

1 reference

12 December 2020

Monoclonal Antibody K1 Reacts With Epithelial Mesothelioma but not With Lung Adenocarcinoma

1 reference

12 December 2020

Localization of mesothelin in epithelial ovarian cancer

1 reference

12 December 2020

Advances in malignant mesothelioma

1 reference

12 December 2020

Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium

1 reference

12 December 2020

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer

1 reference

12 December 2020

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

1 reference

12 December 2020

Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium

1 reference

12 December 2020

Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers

1 reference

12 December 2020

Mesothelin targeted cancer immunotherapy

1 reference

12 December 2020

Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin

1 reference

12 December 2020

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

1 reference

12 December 2020

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

1 reference

12 December 2020

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

1 reference

12 December 2020

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.

1 reference

12 December 2020

Suppression of cell death by the secretory form of N-terminal ERC/mesothelin.

1 reference

12 December 2020

A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5.

1 reference

12 December 2020

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23225411%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

23225411

1 reference